Crédit Industriel et Commercial’s Kezar Life Sciences KZR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-53,600
Closed -$398K – 386
2026
Q1
$398K Buy
+53,600
New +$349K 0.03% 261

Crédit Industriel et Commercial's KZR Position: Q2 2026 in Review

Crédit Industriel et Commercial sold out of Kezar Life Sciences (KZR) in Q2 2026, closing a stake of 53,600 shares — an estimated $398K sold.

Crédit Industriel et Commercial first reported a position in KZR in Q1 2026 and held it in 1 quarter. The position peaked at $398K in Q1 2026. 0 funds tracked by Wall St. Rank hold KZR as of Q2 2026.

  • Crédit Industriel et Commercial reported no remaining Kezar Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Crédit Industriel et Commercial sold 53,600 Kezar Life Sciences shares in Q2 2026, an estimated $398K.
  • Crédit Industriel et Commercial first reported a position in Kezar Life Sciences in Q1 2026 and held it in 1 quarter.
  • Crédit Industriel et Commercial's Kezar Life Sciences position peaked at $398K in Q1 2026.
  • 0 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2026.

Based on Crédit Industriel et Commercial's 13F filing for Q2 2026, filed 24 Jul 2026.